TP53 and hepatocellular carcinoma: It showed in vitro anticancer activity against human hepatoma cells (SMMC-7721) with IC50 = 50 μM/L by reducing the cell proliferation and inducing apoptosis by increasing the tumor suppressor gene p53 (Subramanian et al., 2015).